WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Transplant Product Efficacy Framework 20131211 v2, defined time point including 12 months, Graft Loss can be assessed at defined time point, Glomerular Filtration Rate (GFR) can be measured by cold-iothalamate method, Decreased GFR is associated with Cardiovascular (CV) risk, urine output is measured as decreased, defined time points between 3 months, Death can be assessed at defined time point, Efficacy Failure Events include Graft Loss, Concepts (e.g. Graft survival) are denoted by solid round-edged rectangle, defined time point including 12 months, Filtration rates can be thresholded at 60 mL/min, Date of Graft Loss is earliest occurance of Death, Graft Loss is the inverse of Graft Survival, Renal function/ Impairment leads to Long Term Dialysis, Study treatments include Belatacept, Clinically suspected Acute Rejection can be defined by graft tenderness, Death may result from infection, Death is assessed at Follow-up, Banff grade can be IIA, Glomerular Filtration Rate (GFR) is measured as Elevated GFR